GlassScriptPhysician profile
Araj Sidki
NPI 1285014126
$4,638.04
in general payments reported to CMS, 2019-2025
17 companies · $1,706 in 2025
The $1,706 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $244 · 2021: $146 · 2022: $555 · 2023: $472 · 2024: $1,515 · 2025: $1,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,255 · Travel and Lodging: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.71 |
| Travel and Lodging | $1,437.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,451.76 | 2022-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $1,187.63 | 2025 | Evoke |
| Scilex Pharmaceuticals INC. | $457.93 | 2021-2025 | Ztlido |
| Abbvie INC. | $325.20 | 2020-2025 | |
| Abbott Laboratories | $271.36 | 2022 | |
| Medtronic, INC. | $253.01 | 2021-2023 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $200.81 | 2023 | Intracept |
| Vertos Medical, INC. | $118.18 | 2022-2024 | Mild Device Kit |
| Si-Bone, INC. | $73.32 | 2024 | |
| Collegium Pharmaceutical, INC. | $72.57 | 2022 | |
| Protega Pharmaceutials INC | $60.76 | 2025 | Roxybond |
| Avanos Medical | $52.70 | 2025 | Standard Rf Disposables |
| Grt US Holding, INC. | $31.99 | 2022 | |
| Djo, LLC | $30.94 | 2025 | Cmf |
| Baudax Bio INC. | $19.36 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.66 | 2024 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Araj Sidki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.